BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 10799880)

  • 1. Inhibition of functional T cell priming and contact hypersensitivity responses by treatment with anti-secondary lymphoid chemokine antibody during hapten sensitization.
    Engeman TM; Gorbachev AV; Gladue RP; Heeger PS; Fairchild RL
    J Immunol; 2000 May; 164(10):5207-14. PubMed ID: 10799880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+ and CD8+ T cell priming for contact hypersensitivity occurs independently of CD40-CD154 interactions.
    Gorbachev AV; Heeger PS; Fairchild RL
    J Immunol; 2001 Feb; 166(4):2323-32. PubMed ID: 11160289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of hapten inhibits in vivo induction of specific cytotoxic CD8+ T cells mediating tissue inflammation: a role for regulatory CD4+ T cells.
    Desvignes C; Etchart N; Kehren J; Akiba I; Nicolas JF; Kaiserlian D
    J Immunol; 2000 Mar; 164(5):2515-22. PubMed ID: 10679089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1 receptor signaling is required at multiple stages of sensitization and elicitation of the contact hypersensitivity response.
    Kish DD; Gorbachev AV; Fairchild RL
    J Immunol; 2012 Feb; 188(4):1761-71. PubMed ID: 22238457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells.
    Xu H; DiIulio NA; Fairchild RL
    J Exp Med; 1996 Mar; 183(3):1001-12. PubMed ID: 8642241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity.
    Schwarz A; Maeda A; Wild MK; Kernebeck K; Gross N; Aragane Y; Beissert S; Vestweber D; Schwarz T
    J Immunol; 2004 Jan; 172(2):1036-43. PubMed ID: 14707077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glucocorticoid-induced TNF receptor-related protein (GITR)-GITR ligand pathway acts as a mediator of cutaneous dendritic cell migration and promotes T cell-mediated acquired immunity.
    Kamimura Y; Iwai H; Piao J; Hashiguchi M; Azuma M
    J Immunol; 2009 Mar; 182(5):2708-16. PubMed ID: 19234165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance.
    Riemann H; Schwarz A; Grabbe S; Aragane Y; Luger TA; Wysocka M; Kubin M; Trinchieri G; Schwarz T
    J Immunol; 1996 Mar; 156(5):1799-803. PubMed ID: 8596029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ T cells regulate CD8+ T cell-mediated cutaneous immune responses by restricting effector T cell development through a Fas ligand-dependent mechanism.
    Gorbachev AV; Fairchild RL
    J Immunol; 2004 Feb; 172(4):2286-95. PubMed ID: 14764697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of effector CD8+ T cells in contact hypersensitivity occurs independently of CD4+ T cells.
    Xu H; Banerjee A; Dilulio NA; Fairchild RL
    J Immunol; 1997 May; 158(10):4721-8. PubMed ID: 9144485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40 engagement enhances antigen-presenting langerhans cell priming of IFN-gamma-producing CD4+ and CD8+ T cells independently of IL-12.
    Gorbachev AV; Fairchild RL
    J Immunol; 2004 Aug; 173(4):2443-52. PubMed ID: 15294958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of Langerhans cell-derived IL-18 to contact hypersensitivity.
    Wang B; Feliciani C; Howell BG; Freed I; Cai Q; Watanabe H; Sauder DN
    J Immunol; 2002 Apr; 168(7):3303-8. PubMed ID: 11907086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil Cathepsin G Regulates Dendritic Cell Production of IL-12 during Development of CD4 T Cell Responses to Antigens in the Skin.
    Kish DD; Min S; Dvorina N; Baldwin WM; Stohlman SA; Fairchild RL
    J Immunol; 2019 Feb; 202(4):1045-1056. PubMed ID: 30617225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Langerhans cells beta 2-adrenoceptors: role in migration, cytokine production, Th priming and contact hypersensitivity.
    Maestroni GJ; Mazzola P
    J Neuroimmunol; 2003 Nov; 144(1-2):91-9. PubMed ID: 14597102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of dectin-2 in ultraviolet radiation-induced tolerance.
    Aragane Y; Maeda A; Schwarz A; Tezuka T; Ariizumi K; Schwarz T
    J Immunol; 2003 Oct; 171(7):3801-7. PubMed ID: 14500681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity.
    Nuriya S; Yagita H; Okumura K; Azuma M
    Int Immunol; 1996 Jun; 8(6):917-26. PubMed ID: 8671681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hapten application to the skin induces an inflammatory program directing hapten-primed effector CD8 T cell interaction with hapten-presenting endothelial cells.
    Kish DD; Volokh N; Baldwin WM; Fairchild RL
    J Immunol; 2011 Feb; 186(4):2117-26. PubMed ID: 21239709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity.
    Wang B; Fujisawa H; Zhuang L; Freed I; Howell BG; Shahid S; Shivji GM; Mak TW; Sauder DN
    J Immunol; 2000 Dec; 165(12):6783-90. PubMed ID: 11120799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction and regulation of T-cell priming for contact hypersensitivity.
    Gorbachev AV; Fairchild RL
    Crit Rev Immunol; 2001; 21(5):451-72. PubMed ID: 11942559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR8 regulates contact hypersensitivity by restricting cutaneous dendritic cell migration to the draining lymph nodes.
    Yabe R; Shimizu K; Shimizu S; Azechi S; Choi BI; Sudo K; Kubo S; Nakae S; Ishigame H; Kakuta S; Iwakura Y
    Int Immunol; 2015 Apr; 27(4):169-81. PubMed ID: 25344933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.